LabCorp

LabCorp names Dr. Brian Caveney as enterprise-wide chief medical officer

Tuesday, August 29, 2017

LabCorp, a global life sciences company, announced that Dr. Brian Caveney, a nationally recognized health-policy expert who currently serves as chief medical officer of Blue Cross and Blue Shield of North Carolina (Blue Cross NC), will fill a newly created role as enterprise-wide chief medical officer of LabCorp, effective Sept. 25. Caveney will report to David P. King, chairman and CEO of LabCorp.

[Read More]

LabCorp to acquire Chiltern for $1.2B in cash

Monday, July 31, 2017

LabCorp, a global life sciences company, and Chiltern, a specialty CRO, announced that LabCorp will acquire Chiltern pursuant to a definitive agreement with Chiltern’s shareholders in an all-cash transaction valued at approximately $1.2 billion. Once the transaction is complete, Chiltern will become part of LabCorp’s Covance segment.

[Read More]

A cautiously optimistic healthcare M&A outlook for 2017

Monday, February 13, 2017

Although 2016 was a lackluster year for megadeals in healthcare, a recent flurry of big deals has Wall Street investors cautiously optimistic that 2017 will bring new mergers and big-ticket acquisitions. An increasingly competitive landscape in healthcare, coupled with signs that the new U.S. presidential administration may usher in more business-friendly policies, could spur major deals in the upcoming year.

[Read More]

LabCorp to acquire assets of Mount Sinai Clinical Outreach Laboratories

Wednesday, January 11, 2017

Laboratory Corporation of America Holdings (LabCorp), a life sciences company, and the Mount Sinai Health System, one of the largest health systems in metropolitan New York City, have entered into a definitive agreement for LabCorp to acquire assets of Mount Sinai’s Clinical Outreach Laboratories. When the transaction is complete, LabCorp will be available to provide comprehensive laboratory services to physicians and patients that currently use Mount Sinai’s outreach laboratory.

[Read More]

LabCorp to acquire Sequenom

Thursday, July 28, 2016

Laboratory Corporation of America Holdings (LabCorp), a healthcare diagnostics company, and Sequenom, a pioneer in non-invasive prenatal testing (NIPT) for reproductive health, have entered into a definitive agreement and plan of merger under which LabCorp would acquire all of the outstanding shares of Sequenom in a cash tender offer for $2.40 per share, or an equity value of $302 million, which represents a total enterprise value of approximately $371 million, including net indebtedness.

[Read More]